Cannabis Law Report
AUGUST 18, 2022
Using the data collected, ACS Laboratory extracted the strictest requirements per category to create the National Hemp Testing Panel and corresponding Certificate of Analysis. With that research, they created elaborate matrices to compare each mandate.
Canna Law Blog
SEPTEMBER 6, 2023
Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 29, 2021
In recent months, the DEA has issued a select number of licenses to several groups in the US to allow for the cultivation of Cannabis for scientific research purposes. Under the federal licensing regime, BRC is only allowed to source genetics and starting material from DEA-compliant or federally legal sources.
Cannabis Law Report
MAY 29, 2022
8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA).
The Blunt Truth
MARCH 10, 2020
The latter requires extensive vetting , including analyses of the underlying target condition and other related available treatments, conducting a cost benefit analysis from clinical data, as well as strategizing on how drug risks may be identified and mitigated. CBD Class Action Litigation. Other CBD companies, like CV Sciences Inc.
Cannabis Law Report
AUGUST 18, 2022
The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. . However, change appears imminent.
Cannabis Law Report
JULY 27, 2021
If successful, researchers will analyze the data to quantify global gene expression and will use available pipelines to determine differential gene expression between the three lines sampled. In addition, the Portuguese operation was also granted certification of compliance with GACP and IMC-GAP.
Expert insights. Personalized for you.
52 
Let's personalize your content